| UniProt ID | PYRG2_HUMAN | |
|---|---|---|
| UniProt AC | Q9NRF8 | |
| Protein Name | CTP synthase 2 | |
| Gene Name | CTPS2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 586 | |
| Subcellular Localization | ||
| Protein Description | Catalyzes the ATP-dependent amination of UTP to CTP with either L-glutamine or ammonia as the source of nitrogen. Constitutes the rate-limiting enzyme in the synthesis of cytosine nucleotides.. | |
| Protein Sequence | MKYILVTGGVISGIGKGIIASSIGTILKSCGLRVTAIKIDPYINIDAGTFSPYEHGEVFVLNDGGEVDLDLGNYERFLDINLYKDNNITTGKIYQHVINKERRGDYLGKTVQVVPHITDAVQEWVMNQAKVPVDGNKEEPQICVIELGGTIGDIEGMPFVEAFRQFQFKAKRENFCNIHVSLVPQLSATGEQKTKPTQNSVRALRGLGLSPDLIVCRSSTPIEMAVKEKISMFCHVNPEQVICIHDVSSTYRVPVLLEEQSIVKYFKERLHLPIGDSASNLLFKWRNMADRYERLQKICSIALVGKYTKLRDCYASVFKALEHSALAINHKLNLMYIDSIDLEKITETEDPVKFHEAWQKLCKADGILVPGGFGIRGTLGKLQAISWARTKKIPFLGVCLGMQLAVIEFARNCLNLKDADSTEFRPNAPVPLVIDMPEHNPGNLGGTMRLGIRRTVFKTENSILRKLYGDVPFIEERHRHRFEVNPNLIKQFEQNDLSFVGQDVDGDRMEIIELANHPYFVGVQFHPEFSSRPMKPSPPYLGLLLAATGNLNAYLQQGCKLSSSDRYSDASDDSFSEPRIAELEIS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 12 | Phosphorylation | LVTGGVISGIGKGII EEECCCCCCCCCHHH | 23.19 | 21712546 | |
| 51 | Phosphorylation | NIDAGTFSPYEHGEV CCCCCCCCCCCCCCE | 26.81 | 26074081 | |
| 53 | Phosphorylation | DAGTFSPYEHGEVFV CCCCCCCCCCCCEEE | 21.25 | 26074081 | |
| 83 | Phosphorylation | RFLDINLYKDNNITT EEEEEEEECCCCCCC | 16.29 | 22210691 | |
| 90 | Phosphorylation | YKDNNITTGKIYQHV ECCCCCCCCCEEEHH | 32.45 | 22210691 | |
| 92 | Ubiquitination | DNNITTGKIYQHVIN CCCCCCCCEEEHHHC | 35.83 | - | |
| 94 | Phosphorylation | NITTGKIYQHVINKE CCCCCCEEEHHHCHH | 8.96 | 22210691 | |
| 100 | Ubiquitination | IYQHVINKERRGDYL EEEHHHCHHHCCCCC | 41.28 | - | |
| 169 | Methylation | AFRQFQFKAKRENFC HHHHHCHHHCCCCCC | 42.06 | - | |
| 189 | Phosphorylation | LVPQLSATGEQKTKP ECCCCCCCCCCCCCC | 37.56 | 24719451 | |
| 195 | Ubiquitination | ATGEQKTKPTQNSVR CCCCCCCCCCHHHHH | 53.77 | - | |
| 200 | Phosphorylation | KTKPTQNSVRALRGL CCCCCHHHHHHHHHC | 11.80 | 24114839 | |
| 205 | Methylation | QNSVRALRGLGLSPD HHHHHHHHHCCCCCC | 36.99 | - | |
| 216 | Glutathionylation | LSPDLIVCRSSTPIE CCCCEEEEECCCCHH | 2.50 | 22555962 | |
| 218 | Phosphorylation | PDLIVCRSSTPIEMA CCEEEEECCCCHHHH | 33.18 | 24719451 | |
| 219 | Phosphorylation | DLIVCRSSTPIEMAV CEEEEECCCCHHHHH | 20.89 | 28348404 | |
| 220 | Phosphorylation | LIVCRSSTPIEMAVK EEEEECCCCHHHHHH | 29.54 | 28348404 | |
| 261 | Phosphorylation | PVLLEEQSIVKYFKE EEEECCHHHHHHHHH | 32.40 | 21406692 | |
| 264 | Ubiquitination | LEEQSIVKYFKERLH ECCHHHHHHHHHHCC | 43.21 | 21890473 | |
| 264 | Ubiquitination | LEEQSIVKYFKERLH ECCHHHHHHHHHHCC | 43.21 | 21890473 | |
| 277 | Phosphorylation | LHLPIGDSASNLLFK CCCCCCCHHHHHHHH | 28.52 | 22210691 | |
| 279 | Phosphorylation | LPIGDSASNLLFKWR CCCCCHHHHHHHHHH | 31.78 | 22210691 | |
| 336 | Phosphorylation | NHKLNLMYIDSIDLE HCCCCEEEEEECCHH | 12.54 | - | |
| 346 | Phosphorylation | SIDLEKITETEDPVK ECCHHHHCCCCCCHH | 48.17 | 21406692 | |
| 348 | Phosphorylation | DLEKITETEDPVKFH CHHHHCCCCCCHHHH | 36.72 | 21406692 | |
| 353 | Ubiquitination | TETEDPVKFHEAWQK CCCCCCHHHHHHHHH | 46.52 | - | |
| 360 | Ubiquitination | KFHEAWQKLCKADGI HHHHHHHHHHHCCCC | 45.19 | - | |
| 378 | Phosphorylation | GGFGIRGTLGKLQAI CCCCCCCHHHHHHHH | 23.61 | - | |
| 386 | Phosphorylation | LGKLQAISWARTKKI HHHHHHHHHHHCCCC | 20.07 | 29496963 | |
| 389 | Methylation | LQAISWARTKKIPFL HHHHHHHHCCCCCCH | 40.60 | - | |
| 466 | Ubiquitination | TENSILRKLYGDVPF CCHHHHHHHHCCCCC | 42.49 | - | |
| 548 | Phosphorylation | LGLLLAATGNLNAYL HHHHHHHHCCHHHHH | 22.46 | 30576142 | |
| 562 | Phosphorylation | LQQGCKLSSSDRYSD HHCCCCCCCCCCCCC | 17.19 | 22167270 | |
| 563 | Phosphorylation | QQGCKLSSSDRYSDA HCCCCCCCCCCCCCC | 46.85 | 22167270 | |
| 564 | Phosphorylation | QGCKLSSSDRYSDAS CCCCCCCCCCCCCCC | 23.80 | 23401153 | |
| 566 | Methylation | CKLSSSDRYSDASDD CCCCCCCCCCCCCCC | 34.50 | - | |
| 567 | Phosphorylation | KLSSSDRYSDASDDS CCCCCCCCCCCCCCC | 18.85 | 22167270 | |
| 568 | Phosphorylation | LSSSDRYSDASDDSF CCCCCCCCCCCCCCC | 27.82 | 22167270 | |
| 571 | Phosphorylation | SDRYSDASDDSFSEP CCCCCCCCCCCCCCC | 47.11 | 29255136 | |
| 574 | Phosphorylation | YSDASDDSFSEPRIA CCCCCCCCCCCCCEE | 35.35 | 29255136 | |
| 576 | Phosphorylation | DASDDSFSEPRIAEL CCCCCCCCCCCEEEE | 51.12 | 22167270 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 568 | S | Phosphorylation | Kinase | CSNK1A1 | P48729 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PYRG2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PYRG2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PYRG2_HUMAN | CTPS2 | physical | 16189514 | |
| FGFR1_HUMAN | FGFR1 | physical | 21988832 | |
| RL23A_HUMAN | RPL23A | physical | 21988832 | |
| RL37A_HUMAN | RPL37A | physical | 21988832 | |
| HSF1_HUMAN | HSF1 | physical | 22863883 | |
| LRSM1_HUMAN | LRSAM1 | physical | 22863883 | |
| MTMR2_HUMAN | MTMR2 | physical | 22863883 | |
| PLIN3_HUMAN | PLIN3 | physical | 22863883 | |
| PYRG2_HUMAN | CTPS2 | physical | 25416956 | |
| PYRG1_HUMAN | CTPS1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-567; SER-568; SER-571AND SER-574, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-568; SER-571 ANDSER-574, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-568 AND SER-571, ANDMASS SPECTROMETRY. | |